The Discounted Cash Flow (DCF) valuation of Jagson Pal Pharmaceuticals Ltd (JAGSNPHARM.NS) is 48.06 INR. With the latest stock price at 209.68 INR, the upside of Jagson Pal Pharmaceuticals Ltd based on DCF is -77.1%.
Based on the latest price of 209.68 INR and our DCF valuation, Jagson Pal Pharmaceuticals Ltd (JAGSNPHARM.NS) is a sell. selling JAGSNPHARM.NS stocks now will result in a potential gain of 77.1%.
| Range | Selected | |
| WACC / Discount Rate | 12.9% - 15.4% | 14.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 40.63 - 59.62 | 48.06 |
| Upside | -80.6% - -71.6% | -77.1% |